Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Invion.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
Health & Biotech
ASX Health Stocks: A breakthrough for CAR T therapy? Arovella signs deal to advance CAR-iNKT platform
Health & Biotech
ASX Health Stocks: Starpharma full steam ahead on VIRALEZE study, Dimerix to use QYTOVRA as brand name
Health & Biotech
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
Health & Biotech
ASX Health Stocks: INOVIQ says its breast cancer technology beats currently available tests
News
Market Highlights: Wild ride on Wall Street, Medibank’s lawsuit, and 5 ASX small caps to watch today
News
Market Highlights: US recession fears, tighter crypto rules, and 5 ASX small caps to watch on Monday
Health & Biotech
Check Up: These 3 biotechs join the elite ASX 300 this week – and it could be a game-changer
Health & Biotech
ASX Health Stocks: Invion surges 17pc after saying its lead drug can kill anal cancer
News
Top 10 at 10: Which ASX stocks are flying and fumbling today?
Health & Biotech
ASX Health Stocks: Invion proves photodynamic therapy is effective against the Zika virus
Health & Biotech
ASX Health Stocks: HitIQ and Volpara prove world class technology after signing major US deals
News
Market highlights and 5 ASX small caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Invion demonstrates efficacy, Biotron gets feedback from the FDA
Health & Biotech
